SENORES PHARMACEUTICALS
Back to Cashflow Statement
|
SENORES PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹62 Cr | ₹-46 Cr | ₹-26 Cr | ₹-1.08 Cr | ₹-10 Cr |
What is the latest Cash Flow from Operating Activities ratio of SENORES PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹62 Cr |
| Mar2025 | ₹-46 Cr |
| Mar2024 | ₹-26 Cr |
| Mar2023 | ₹-1.08 Cr |
| Mar2022 | ₹-10 Cr |
How is Cash Flow from Operating Activities of SENORES PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹62 Cr | Positive | |
| Mar2025 | ₹-46 Cr | Negative | |
| Mar2024 | ₹-26 Cr | Negative | |
| Mar2023 | ₹-1.08 Cr | Negative | |
| Mar2022 | ₹-10 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,764.9 Cr | -1.9% | -1.6% | 96.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -1.9% |
-1.6% |
96.3% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses